Natalia Espinola (Natalia Espínola)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Rheumatoid Arthritis

Radical Prostatectomy

Top Venues

PharmacoEconomics - open

Cadernos de saude publica

Revista peruana de medicina experimental y salud publica

Archivos argentinos de pediatria

This page only lists publications with an associated author ORCID identifier.

Publications

Germán Guaresti, Marcos Clausen, Natalia Espinola, Andrea Graciano, Leila Guarnieri, Lucas Perelli, Andrea Alcaraz
Childhood obesity and sugar-sweetened beverages in Río Negro: Burden of disease and expected impact of Law no. 27642 on the Promotion of Healthy Eating. Archivos argentinos de pediatria (2024)
Carlos Rojas-Roque, Constanza Silvestrini, Fernando J Argento, Daniela Sugg, Federico Augustovski, Jesica Coelli, Natalia Espinola
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics - open 8 (4) (2024)
Carlos Rojas-Roque, Constanza Silvestrini, Fernando J Argento, Daniela Sugg, Federico Augustovski, Jesica Coelli, Natalia Espinola
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics - open 8 (4) (2024)
Natalia Espinola, Constanza Silvestrini, Carla Colaci, Daniela Sugg, Carlos Rojas-Roque, Jesica Coelli, Federico Augustovski
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina. PharmacoEconomics - open 8 (5) (2024)
Natalia Espinola, Constanza Silvestrini, Carla Colaci, Daniela Sugg, Carlos Rojas-Roque, Jesica Coelli, Federico Augustovski
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina. PharmacoEconomics - open 8 (5) (2024)
Natalia Espinola, Anastasia Secco, Dario Balan, Diego Kanevsky, Guido Calvi, Pierre Morisset, Ariel Esteban Bardach, Federico Augustovski
Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina. Revista peruana de medicina experimental y salud publica 41 (2) (2024)
Natalia Espinola, Constanza Silvestrini, Carla Colaci, Daniela Sugg, Carlos Rojas-Roque, Jesica Coelli, Federico Augustovski
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina. PharmacoEconomics - open 8 (5) (2024)
Natalia Espinola, Constanza Silvestrini, Carla Colaci, Daniela Sugg, Carlos Rojas-Roque, Jesica Coelli, Federico Augustovski
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina. PharmacoEconomics - open (2024)
Natalia Espinola, Anastasia Secco, Dario Balan, Diego Kanevsky, Guido Calvi, Pierre Morisset, Ariel Esteban Bardach, Federico Augustovski
Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina. Revista peruana de medicina experimental y salud publica 41 (2) (2024)
Carlos Rojas-Roque, Constanza Silvestrini, Fernando J Argento, Daniela Sugg, Federico Augustovski, Jesica Coelli, Natalia Espinola
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics - open (2024)
Carlos Rojas-Roque, Constanza Silvestrini, Fernando J Argento, Daniela Sugg, Federico Augustovski, Jesica Coelli, Natalia Espinola
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina. PharmacoEconomics - open 8 (4) (2024)
Lucas Perelli, Andrea Alcaraz, Cid Manso de Mello Vianna, Natalia Espinola, Federico Rodriguez Cairoli, Ariel Esteban Bardach, Alfredo Palacios, Dario Balan, Paula Johns, Federico Augustovski, Andrés Pichón-Riviere
Health and economic burden of sugar-sweetened beverages consumption in Brazil. Cadernos de saude publica 39 (12) (2023)
Lucas Perelli, Andrea Alcaraz, Cid Manso de Mello Vianna, Natalia Espinola, Federico Rodriguez Cairoli, Ariel Esteban Bardach, Alfredo Palacios, Dario Balan, Paula Johns, Federico Augustovski, Andrés Pichón-Riviere
Health and economic burden of sugar-sweetened beverages consumption in Brazil. Cadernos de saude publica 39 (12) (2023)
Lucas Perelli, Andrea Alcaraz, Cid Manso de Mello Vianna, Natalia Espinola, Federico Rodriguez Cairoli, Ariel Esteban Bardach, Alfredo Palacios, Dario Balan, Paula Johns, Federico Augustovski, Andrés Pichón-Riviere
Health and economic burden of sugar-sweetened beverages consumption in Brazil. Cadernos de saude publica 39 (12) (2023)
Lucas Perelli, Andrea Alcaraz, Cid Manso de Mello Vianna, Natalia Espinola, Federico Rodriguez Cairoli, Ariel Esteban Bardach, Alfredo Palacios, Dario Balan, Paula Johns, Federico Augustovski, Andrés Pichón-Riviere
Health and economic burden of sugar-sweetened beverages consumption in Brazil. Cadernos de saude publica 39 (12) (2023)
Anastasia Secco, Verónica Alfie, Natalia Espinola, Ariel Esteban Bardach
[Epidemiology, resource use and costs of rheumatoid arthritis in Argentina]. Revista peruana de medicina experimental y salud publica 37 (3) (2021)